Skip to main content
. 2017 Mar 10;8(15):25582–25598. doi: 10.18632/oncotarget.16106

Table 2. Percentage (%) cells expressing β-tubulin III, SOX-2 and nestin in glioma primary cultures maintained in standard culture conditions (St-M) and in DMEM/F12 medium serum free with EGF, b-FGF and B27 supplement for neurosphere generation (GSC-M).

β-tubulin III SOX-2 nestin
St-M GSC-M St-M GSC-M St-M GSC-M
1 92.35 ± 2.62 92.91 ±2.65 90.4 ± 4.52 97.84 ± 4.89 94.68 ± 3.73 95.92 ± 4.80
2 74.71 ± 3.74 / 14.56 ± 0.73 / 87.14 ± 2.36 /
3 80.1 ± 4.01 / 28.3 ± 1.42 / 79.98 ± 4.00 /
4 97.51 ± 4.88 / 8.01 ± 0.40 / 84.25 ± 4.21 /
5 38.77 ± 1.94 / 13.78 ± 0.69 / 43.25 ± 2.16 /
6 82.53 ± 2.13 / 35.99 ± 1.80 / 77.96 ± 3.90 /
7 90.77 ± 3.54 99.93 ±4.20 69.33 ± 3.47 84.01 ± 3.70 90.02 ± 4.50 99.99 ± 5.00
8 95.31 ± 4.77 98.86 ± 4.14 82.03 ± 4.10 84.71 ± 2.94 96.76 ± 4.84 99.35 ± 2.87
9 88.74 ± 1.44 94.78 ± 3.54 69.3 ± 3.47 80.30 ± 3.02 90.87 ± 3.54 99.63 ± 3.98
10 60.9 ± 3.05 81.30 ± 4.07 81.00 ± 3.05 65.73 ± 3.29 93.9 ± 2.70 95.40 ± 4.77

Data shown are presented as the mean values of one out of two independent experiments in duplicates ± SD.